Illinois adult-use cannabis sales totaled $1.51 billion in 2025, marking a 12.5% decline from 2024 and falling below 2022 levels. The state released figures for November and December on Friday, showing December sales at $116.6 million, up 5.6% from the prior month but down 23.9% year-over-year. This update follows a major historical revision in November, triggered by the shift to a new tracking system that improved sales accuracy.
Sequential Gains Mask Annual Contraction
December's $116.6 million in adult-use sales represented a 2.2% increase on a per-day basis over November, offering a modest sequential lift. Yet year-over-year comparisons reveal deeper challenges: the -23.9% drop improved slightly from November's -26.1%, signaling persistent demand erosion. Year-to-date figures underscore the trend, with 2025 sales lagging behind the 5.4% growth seen in 2024's $1.72 billion total.
Metrc Switch Resolves Data Gaps, Reveals Past Inaccuracies
The November release explained delays stemmed from transitioning to Metrc, a seed-to-sale tracking platform now used statewide. This system captures actual sales at checkout, including discounts, correcting prior reports that overstated figures with pre-discount prices. Officials conducted a thorough review, revising historical data through October and restoring timely reporting after months of silence—the previous adult-use update covered only May.
Post-Boom Slowdown Signals Market Maturity
Adult-use sales exploded 106% in 2021 following legalization, then moderated to 13% growth in 2022 and 5% in 2023. The 2025 contraction reflects a maturing market, where initial novelty fades amid expanded retail outlets and consumer habituation. Medical cannabis data remains stalled; April's last report showed $19.7 million in sales, down 1.6% sequentially and 13.2% year-over-year, highlighting parallel pressures on the state's dual programs.
Outlook Hinges on Data Reliability and Demand Recovery
With Metrc now operational, Illinois gains clearer visibility into sales dynamics, essential for policymakers monitoring tax revenue and industry health. Sustained declines raise questions about oversupply or shifting consumer preferences, even as sequential upticks hint at seasonal resilience. Future releases will test whether this represents a temporary dip or a new baseline for a post-boom era.
